Evidence map›Paper›PMID 41257217›Full record

ArticleACS catalysis2020

General Access to

Maheshwerreddy Chilamari, Jacob R Immel, Steven Bloom

Abstract read
In one paragraph

Article in ACS catalysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Flavin Catalysts in Organic Synthesis.Angewandte Chemie (International ed. in English) · 2026
    Review
  2. Article
  3. Fused 3D boron heterocyclesChemical science · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. A Vitamin BAngewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  13. A Vitamin BAngewandte Chemie (International ed. in English) · 2022
    Article
  14. PeptideACS central science · 2022
    Article
  15. Article
  16. The Impact of Boron Hybridisation on Photocatalytic Processes.Angewandte Chemie (International ed. in English) · 2022
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maheshwerreddy ChilamariDepartment of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045, United States.
Jacob R ImmelDepartment of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045, United States.
Steven BloomDepartment of Medicinal Chemistry, University of Kansas, Lawrence, Kansas 66045, United States.ORCID 0000-0002-4205-4459

Funding

Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI OROZCO, ROBIN C. · 2016 to 2025
$23.9M
NIGMS NIH HHS P20 GM113117
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biocompatibleboronic acidflavinphotoredox catalysisradical

Identifiers

PMID41257217
PMCPMC12622572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.